B2B email list accuracy is the metric most data buyers never test until their bounce rate forces the issue. You paid for a “verified” B2B email list. You ran your first campaign. Your bounce rate came back at 38%. Your sending domain is now flagged. The provider says the data was accurate at time of […]
Healthcare HCP Data: The Complete Guide for Pharma Marketers (2026)
Pharmaceutical sales reps visited physicians over 700 million times a year before 2020. Today, many physicians have closed their doors to in-person visits entirely. The access model broke. Healthcare HCP data is how pharma and medical device marketers reach physicians now. 12 min read | Last updated: March 2026 What is healthcare HCP data? Healthcare […]
What Is Data Enrichment? (And Does Your CRM Need It?)
Your sales team is calling people who left their jobs six months ago. Your nurture sequences are firing at contacts whose email addresses bounced 90 days ago. And nobody flagged it — because your CRM looks full. So do you need data Enrichment? What Is Data Enrichment? (And Does Your CRM Need It?) 9 min […]
ZoomInfo vs Apollo vs SparkDBI: B2B Data Quality Compared (2026)
Making a b2b data provider comparison in 2026 means cutting through a lot of noise. ZoomInfo dominates the conversation. Apollo wins on price. But neither of those facts tells you which platform will actually deliver pipeline for your team. Your B2B database is costing you revenue – and you probably don’t know exactly how much. […]
The Complete Guide to Oncologist Email Lists: How to Reach Cancer Care Specialists in 2026
Quick Stats at a Glance– 18,000+ active oncologists practicing in the United States– $516B+ projected global oncology market by 2028– 95%+ email accuracy from premium HCP data providers like SparkDBI– 40% better response rates with geo-targeted oncologist lists– 6 to 10 decision-makers are involved in the average oncology product purchase 1. Introduction: Why the Oncology […]
Nurse Practitioner Email List: The Complete Guide to Reaching NPs and APRNs in 2026
Mixed (Educational + Commercial) | 11 min read | Last updated: April 2026 There are more than 385,000 licensed Nurse Practitioners in the United States. In 27 states, they have full practice authority — meaning they diagnose, treat, and prescribe without physician oversight. For pharma, medical device, and healthcare technology companies, a verified nurse practitioner […]
CRM Data Decay Rates by Industry: Complete Guide for 2026
Your sales team just spent the morning calling outdated phone numbers. Marketing’s email campaign bounced at a 12% rate. A major deal fell through because your contact changed companies three months ago and nobody updated the CRM. Sound familiar? This isn’t a training problem or a process problem. It’s a data decay problem, and it’s […]
HIPAA vs. GDPR vs. CAN-SPAM: Navigating B2B Data Licensing in 2026
If you are buying a B2B contact list today, you aren’t just buying names and emails. You are buying a legal responsibility. One wrong move with a healthcare provider (HCP) list or an EU-based database can lead to fines that make your quarterly budget look like pocket change. The rules of the game shifted recently. […]
Pharmaceutical Email Marketing: Complete Guide to Reaching Prescribers
Pharmaceutical companies face a unique challenge in 2026. Traditional sales rep visits have declined by over 60% since 2020, yet healthcare professionals are busier than ever. The average physician sees 20+ patients daily, spends 4.5 hours on electronic health records, and receives hundreds of marketing messages each week. In this environment, how does pharmaceutical email […]
Why Your ICP Targeting Fails With Generic B2B Databases (And What Actually Works)
Your sales team just spent another week chasing leads that went nowhere. The contact data looked perfect on paper: right industry, right company size, decision-maker titles that matched your ideal customer profile. But when your reps actually reached out? Thirty percent bounce rates. Disconnected numbers. People who left the company two years ago. Sound familiar? […]









